REDDING, Calif., June 25, 2024 /PRNewswire/ -- According to a new
market research report, 'Research Antibodies and Reagents
Market By Product (Antibodies {Type [Primary,
Secondary]} {Production [mAb, pAb]} {Source [Mouse, Rabbit]}
Research Area} Media, Stains, Enzyme) Technology (ELISA, Flow
Cytometry), Application —Global Forecast to 2031, published by
Meticulous Research®, the research antibodies and
reagents market is projected to reach $6.77
billion by 2031, at a CAGR of 6.5% during the forecast
period 2024–2031.
Download Sample Report Now-
https://www.meticulousresearch.com/download-sample-report/cp_id=5055
Research antibodies are crucial for research in several fields,
including oncology, infectious diseases, cardiology, immunology,
neurology, and stem cell research. Antibodies help in protein
identification and detection, which can be associated with specific
diseases. Furthermore, antibodies are also used in the
identification of novel biomarkers which help in disease
diagnosis.
The research antibodies and reagents market is driven by
the rising proteomics and genomics research studies, increase
in research funding, and growing industry-academia collaboration.
However, the high cost and time for identification and development
of potential antibodies hinder the growth of this market.
Furthermore, the growing applications of antibodies in clinical
trials and medical research, growing research activities in
developing countries, rising preference for protein therapeutics
and personalized medicine, and the growing need for new biomarker
identification are expected to generate growth opportunities for
the players operating in the research antibodies and reagents
market. However, issues related to the quality and stability of
research antibodies pose a major challenge to market growth.
Get a Glimpse Inside: Request Sample Pages-
https://www.meticulousresearch.com/request-sample-report/cp_id=5055
Rising Preference for Protein Therapeutics and Personalized
Medicines Generating Opportunities for Market Players
Therapeutic protein drugs are an important class of medicines
with the capability to serve patients in need of novel therapies.
Advancements in protein-engineering technologies such as mass
spectrometry, advancements in molecular genetics, and progress in
production technologies are driving the protein therapeutics
market, due to which the drug developers are now able to augment
the functional characteristics of desired proteins by maintaining
or enhancing product safety or efficacy.
The fastest growing class of therapeutic proteins is antibodies
that include bispecific mAbs and multispecific fusion proteins, and
mAbs conjugated with small molecule drugs designed for the
treatment of cancers, immune disorders, infections, and other
diseases. Identification of novel proteins for specific disease
applications is a crucial aspect of the research for therapeutic
antibodies. This involves the use of antibodies to identify
proteins through a process called immunodetection. Hence, the
growing preference for protein therapeutics is expected to drive
research activities, boosting the adoption of research antibodies
and reagents.
The key players profiled in this market study are Merck KGaA
(Germany), Thermo Fisher
Scientific Inc. (U.S.), F. Hoffmann La-Roche AG (Switzerland), Agilent Technologies, Inc.
(U.S.), Becton, Dickinson and Company (U.S.), PerkinElmer, Inc.
(U.S.), GenScript Biotech Corporation (U.S.), Bio-Techne
Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Santa Cruz
Biotechnology, Inc. (U.S.), BioLegend, Inc. (U.S.), Abcam Plc
(U.K.), OriGene Technologies, Inc. (U.S.), and Cell Signaling
Technology, Inc. (U.S.).
The global research antibodies and reagents market is segmented
by Product (Antibodies [by Type {Primary Antibodies, Secondary
Antibodies}, Clonality {Monoclonal, Polyclonal, Recombinant},
Source {Mouse, Rabbit, Other Sources}, Research Area {Oncology,
Infectious Diseases, Cardiology, Immunology, Neurology, Stem Cell,
Other Research Areas}], Reagent [Sample Preparation Reagents {Media
and Serum, Stains and Dyes, Probes, Buffers, Solvents}, Antibody
Production Reagents {Enzymes, Proteins}, Other Research Reagents],
Technology (Flow Cytometry, Immunofluorescence, Enzyme-linked
Immunosorbent Assay, Multiplex Immunosorbent Assay, Western Blot,
Immunohistochemistry, Immunoprecipitation, Other Technologies),
Application (Proteomics, Drug Discovery and Development, Genomics),
End User (Pharmaceutical & Biotechnology Companies, Academic
& Research Institutes, Contract Research Organizations), and
geography. The study also evaluates industry competitors and
analyzes the market at regional and country levels.
Have Specific Research Needs? Request a Customized
Report-
https://www.meticulousresearch.com/request-customization/cp_id=5055
Based on product, the research antibodies and reagents market is
segmented into antibodies and reagents. In 2024, the antibodies
segment is expected to account for the largest share of the
research antibodies and reagents market. The large market share of
this segment is attributed to the widespread application of
antibodies in medicine and biomedical research, the requirement of
antibodies for drug development & target identification, high
use in proteomics research, and the growing need for the
development and identification of antibodies for specific diseases
and conditions. The high specificity and sensitivity of antibodies
play a crucial role in biomedical research. The antibodies are used
for several purposes in biomedical research, including the
identification of specific proteins and detecting the presence of
the target protein and its location within a cell.
Based on technology, the global research antibodies and reagents
market is segmented into flow cytometry, immunofluorescence,
enzyme-linked immunosorbent assay, immunoprecipitation, multiplex
immunosorbent assay, immunohistochemistry, western blot, and other
technologies. The enzyme-linked immunosorbent assay segment is
expected to register the fastest CAGR during the forecast period.
The rapid growth of this segment is attributed to the growing
demand for ELISA tests due to an increase in the prevalence of
target diseases worldwide, the ability of ELISA to test large
numbers of samples simultaneously, and advancements in ELISA to
increase accuracy. ELISAs are used to detect a wide range of
analytes, including proteins, antibodies, and small molecules. They
are particularly useful for the diagnosis and monitoring of
infectious diseases, cancers, autoimmune disorders, and allergies.
The development of improved assays requires extensive research
which utilizes research antibodies and reagents.
Based on application, the research antibodies and reagents
market is segmented into proteomics, drug discovery &
development, and genomics. In 2024, the proteomics segment is
expected to account for the largest share of the research
antibodies and reagents market. The large segment share is
attributed to the growing proteomics research activities and the
need for the identification of new protein biomarkers for diseases.
Proteomics study requires the generation of specific and
high-affinity antibodies against a number of proteins. Advancements
in antibody-based technologies, the availability of protein
databases, and rising focus on biomarker discovery through basic
research expand the adoption of research antibodies and reagents
market for proteomics application.
Based on end user, the global research antibodies and reagents
market is segmented into pharmaceutical & biotechnology
companies, academic & research institutes, and contract
research organizations. In 2024, the pharmaceutical &
biotechnology companies segment is expected to account for the
largest share of the research antibodies and reagents market. The
large market share of this segment is attributed to the rising
adoption of research antibodies & regents in the proteomics
research for drug discovery, development, target identification
& validation, and high R&D expenditure of pharmaceutical
& biotechnology companies. The high expenditure of
pharmaceutical & biotechnology companies results in increased
research activities for drug discovery and development. Antibodies
can help quantify, localize, and modulate proteins of interest. For
instance, in 2021, the R&D expenditure of pharmaceutical
companies in the U.S. increased to USD 79.6
billion from 74.7 billion in 2020. Similarly, in
Europe, R&D pharmaceutical
expenses increased to USD 50.3
billion in 2021 from USD 45.1
billion in 2020. (Source: European Federation of
Pharmaceutical Industries and Associations)
Based on geography, in 2024, North
America is expected to account for the largest share of the
global research antibodies and reagents market. The share of this
regional market is attributed to the well-established
healthcare system in the region, higher acceptance of advanced
technologies, rising prevalence of non-communicable diseases,
increasing drug discovery programs and the related rise in
pharmaceutical research & development, rising focus on
proteomics and genomics research, higher research funding, and
presence of many key players in this market.
Browse In-depth Report Now-
https://www.meticulousresearch.com/product/research-antibodies-and-reagents-market-5055
Scope of the Report:
Research Antibodies and Reagents Market,
by Product
- Antibodies
- Type
- Primary Antibodies
- Secondary Antibodies
- o Clonality
- Monoclonal
- Polyclonal
- Recombinant
- Source
- Mouse
- Rabbit
- Other Sources
(Other Sources include humans, apes, sheep, goats, and other
animals)
- Research Area
- Oncology
- Infectious Diseases
- Cardiology
- Immunology
- Neurology
- Stem Cell Research
- Other Research Areas
(Other Research Areas include Ophthalmology and Rare
diseases)
- Reagent
- Sample Preparation Reagents
- Media and Serum
- Stains and Dyes
- Probes
- Buffers
- Solvents
- Antibody Production Reagents
- Other Research Reagents
(Other Research Reagents include fixatives, preservatives,
gels, and reagent preloaded membranes)
Research Antibodies and Reagents Market,
by Technology
- Flow Cytometry
- Immunofluorescence
- Enzyme-linked Immunosorbent Assay
- Multiplex Immunosorbent Assay
- Western Blot
- Immunohistochemistry
- Immunoprecipitation (IP)
- Other Technologies
(Note: Other Technologies include electrophoretic mobility shift
assay (EMSA) and enzyme-linked immunospot)
Research Antibodies and Reagents Market,
by Application
- Proteomics
- Drug Discovery and Development
- Genomics
Research Antibodies and Reagents Market, by End
User
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
- Contract Research Organizations
Research Antibodies and Reagents Market,
by Geography
- North America
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Switzerland
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- South Korea
- Australia
- Singapore
- Rest of Asia-Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
Unlock Opportunities: Buy Now-
https://www.meticulousresearch.com/Checkout/11998366
Related Reports:
Antibody Production Market by Product [Bioreactors (Single use,
Reusable), Chromatography, Filtration, Cell Lines, Media, Buffers,
Resins], Antibody [Monoclonal, Polyclonal], Source [Mice, Rabbit],
Process [Downstream, Upstream] – Global Forecast to 2031
Diagnostic Specialty Antibodies Market by Type (Primary,
Secondary), Clonality (Monoclonal, Polyclonal), Technique (WB,
Rapid Test, IHC, IP), Conjugate, and Application (Dengue, Malaria,
Hepatitis, HIV, E. coli, Tuberculosis, Pneumonia, Cancer)- Forecast
to 2029
Cell Culture Media Market by Product (Serum-free, Chemically
Defined, Classical, Xeno-free/Animal Component Free), Application
(Monoclonal Antibody, Diagnostics, Cancer and Stem Cell Research),
End User (Pharma & Biotech, Academic)- Global Forecast to
2029
About Meticulous Research®
Meticulous Research® was founded in 2010 and incorporated as
Meticulous Market Research Pvt. Ltd. in 2013 as a private limited
company under the Companies Act, 1956. Since its incorporation, the
company has become the leading provider of premium market
intelligence in North America,
Europe, Asia-Pacific, Latin
America, and the Middle
East & Africa.
The name of our company defines our services, strengths, and
values. Since the inception, we have only thrived to research,
analyze, and present the critical market data with great attention
to details. With the meticulous primary and secondary research
techniques, we have built strong capabilities in data collection,
interpretation, and analysis of data including qualitative and
quantitative research with the finest team of analysts. We design
our meticulously analyzed intelligent and value-driven syndicate
market research reports, custom studies, quick turnaround research,
and consulting solutions to address business challenges of
sustainable growth.
Contact:
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Visit Our Website: https://www.meticulousresearch.com/
Connect with us on LinkedIn-
https://www.linkedin.com/company/meticulous-research
Content Source:
https://www.meticulousresearch.com/pressrelease/273/research-antibodies-and-reagents-market-2031
Logo:
https://mma.prnewswire.com/media/1757980/Meticulous_Research_Logo_1.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/research-antibodies-and-reagents-market-to-be-worth-6-77-billion-by-2031---exclusive-report-by-meticulous-research-302181585.html